Chapman A G, Horton R W, Meldrum B S
Epilepsia. 1978 Jun;19(3):293-9. doi: 10.1111/j.1528-1157.1978.tb04492.x.
Clobazam, an anxiolytic 1,5-benzodiazepine, has been evaluated as an anticonvulsant in 2 animal models. In mice showing sound induced seizures, clobazam, 1--4 mg/kg, i.p., blocked seizure responses for 1--2 hr. In Senegalese baboons Papio papio showing photically induced myoclonus or seizures, clobazam, 2--12 mg/kg, i.v., totally prevented such responses for up to 6 hr. In baboons pretreated with allylglycine, 170--185 mg/kg, a similar but briefer protection was induced by clobazam. Neurological toxicity was not prominent (transient, slight nystagmus after clobazam, 2--6 mg/kg; muscular hypotonia after clobazam, 12 mg/kg). The possibility that 1,5-benzodiazepines are superior to 1,4-benzodiazepines in the therapy of epilepsy requires clinical investigation.
氯巴占是一种抗焦虑的1,5-苯二氮䓬类药物,已在两种动物模型中作为抗惊厥药物进行了评估。在表现出声音诱发性癫痫发作的小鼠中,腹腔注射1-4毫克/千克的氯巴占可使癫痫发作反应阻断1-2小时。在表现出光诱发性肌阵挛或癫痫发作的塞内加尔狒狒(巴氏狒狒)中,静脉注射2-12毫克/千克的氯巴占可完全预防此类反应长达6小时。在用170-185毫克/千克烯丙基甘氨酸预处理的狒狒中,氯巴占可诱导类似但持续时间较短的保护作用。神经毒性并不突出(氯巴占2-6毫克/千克后出现短暂、轻微的眼球震颤;氯巴占12毫克/千克后出现肌张力减退)。1,5-苯二氮䓬类药物在癫痫治疗中优于1,4-苯二氮䓬类药物的可能性需要进行临床研究。